PGD2 receptor antagonists for the treatment of inflammatory diseases

Details for Australian Patent Application No. 2006216713 (hide)

Owner Millennium Pharmaceuticals, Inc.

Inventors Ghosh, Shomir; Little, Jeremy D.; Renou, Christelle C.; Elder, Amy E.; Harrison, Sean; Carson, Kenneth G.

Agent Davies Collison Cave

Pub. Number AU-A-2006216713

PCT Pub. Number WO2006/091674

Priority 60/655,927 24.02.05 US

Filing date 23 February 2006

Wipo publication date 31 August 2006

International Classifications

C07D 215/50 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/4365 (2006.01)

A61K 31/4375 (2006.01)

A61K 31/47 (2006.01) - Quinolines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 19/00 (2006.01) Drugs for skeletal disorders

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

13 September 2007 PCT application entered the National Phase

  PCT publication WO2006/091674 Priority application(s): WO2006/091674

15 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  Application withdrawn under section 141(1). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006216715-Modulating plant alkaloids

2006216710-Imidazo (1, 2-A) pyridine compounds as VEGF-R2 inhibitors